BioPharma Dive October 2, 2023
Mark Lambrecht, Senior Director, Health and Life Sciences Practice

When we start to talk about the use of open source technologies in life sciences, leaders fall into two main groups of thought: either we’re going all in on open source, or we’ll never compliantly be able to.

For the former, diving in to open source is exciting in the pursuit of building a more efficient life sciences ecosystem. From molecule discovery to trial enrollment and every step in between, the idea of using open source for innovation, increased speed and improved drug delivery is top of mind for many research teams.

At the same time, the latter group of thinking is still present: in order to maintain regulatory compliance, open source seems like a nonstarter. How could we include...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Analytics, Biotechnology, Pharma / Biotech, Technology
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article